Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel K. Spiegelman currently holds 6,000 shares of Oncothyreon Inc. (ONTY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel K. Spiegelman has been a net seller of ONTY stock. They have purchased $64.4K and sold $35.2M worth of shares.
Daniel K. Spiegelman's most recent insider trade was on Jun 25, 2024, when they sold 6,000 shares at $17.22 per share.
Daniel K. Spiegelman serves as Executive at Oncothyreon Inc. (ONTY). They have executed 195 insider transactions totaling $35.3M over their tenure at the company.
Daniel K. Spiegelman holds the position of Executive at Oncothyreon Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Daniel K. Spiegelman has shown a selling trading pattern, with $64.4K in total purchases and $35.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel K. Spiegelman was on Apr 1, 2019, when they sold $1.2M worth of BMRN shares. This transaction involved 13,473 shares at $89.00 per share.
Daniel K. Spiegelman currently owns 6,000 shares of Oncothyreon Inc. (ONTY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel K. Spiegelman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel K. Spiegelman has 195 Form 4 filings on record as an insider at Oncothyreon Inc..
Set alerts for Daniel K. Spiegelman and 40,000+ other insiders.